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INTRODUCTION
Trisomy 18, also known as Edwards syndrome, is the second most common autosomal trisomic disorder after trisomy 21, commonly known as Down syndrome, observed in liveborn babies 1 . The prevalence of liveborn trisomy-18 babies varies according to country, from 1.0 per 10 000 registered births in [2003] [2004] [2005] [2006] [2007] 3 . As the risk of fetal loss is high (72% at 12 weeks' gestation and 65% at 18 weeks 4 ) and termination of pregnancy is carried out in a large percentage (83-86% 2,4 ) of affected pregnancies, the number of trisomy-18 pregnancies is much higher (an estimated 6.5 in 10 000
2 ) than recorded live births.
In the late first trimester, the combined test is used to screen for trisomy 18, in addition to Down syndrome, providing individual risk calculations for the disorder 5 . Not all women undergo this early form of aneuploidy screening, with wide differences in uptake reported across Europe, varying from 90% in France and Denmark 6, 7 to 20% and 32% in parts of England and The Netherlands, respectively 8, 9 . This means that a substantial proportion of trisomy-18 fetuses remain undetected until the routine 20-week scan. In The Netherlands, more than 90% of the pregnant population undergoes this routine anomaly scan 10 . Some of the major and minor structural anomalies associated with trisomy 18 can be observed in the first trimester 11 -13 , however the sensitivity of ultrasound examination is higher at the time of the 20-week scan 11 . Among other anomalies, subtle ultrasound features of the head and neck are typical of trisomy-18 fetuses, including absent/hypoplastic nasal bone (NB) 14, 15 , thickened nuchal fold 14, 16, 17 , abnormal facial features (flat profile, sloping forehead) 15, 18 , abnormal shape of the skull 15, 17 and micrognathia 19, 20 . Previously we have investigated the performance of the profile markers NB length (NBL), maxilla-nasion-mandible (MNM) angle, fetal profile (FP) line, prenasal thickness (PT), prenasal thickness to nasal bone length (PT:NBL) ratio and prefrontal space ratio (PFSR) in screening for Down syndrome fetuses 21, 22 . The aim of this retrospective study was to investigate the performance of these markers in secondand third-trimester fetuses with trisomy 18 .
METHODS
All cases in which trisomy 18 was suspected and later diagnosed at the mid-trimester scan or at later scans were identified from the databases of the University Medical Centre Groningen, University Medical Centre Utrecht and Saint Antonius Hospital in Nieuwegein, The Netherlands, which act as referral centers. A search was undertaken for good-quality three-dimensional (3D) volumes and two-dimensional (2D) images of trisomy-18 fetuses acquired in the second and third trimesters of the pregnancies of Caucasian women (as our population was mainly Caucasian), between March 2007 and January 2014. All diagnoses were confirmed by karyotyping, either pre-or postnatally.
Only true midsagittal images of the fetal profile were selected and considered for further analysis; we considered as such only profile pictures showing the forehead, nose, lips and chin and maxilla as a single horizontal line without the zygomatic bone. Images with a visible zygomatic bone or ramus of the mandible were excluded. Volumes were acquired during periods of quiescence from fetuses facing the transducer, measuring from as close as possible to the exact midsagittal profile view and with an angle of insonation of < 45
• , with respect to the NB. All ultrasound examinations were performed by experienced sonographers or obstetricians and images were obtained using a GE Voluson 730 Expert ultrasound or E8 system equipped with a RAB4-8 L probe (GE Medical Systems, Kretz Ultrasound, Zipf, Austria). The NBL, PT, PT:NBL ratio, MNM angle, FP line and PFSR were measured as described previously 23 -27 ( Figure 1 ). The FP line was defined as the line that passes through the midpoint of the anterior border of the mandible and the nasion. The nasion was defined as the most anterior point in the junction between the frontal and nasal bones. When the FP line passed lengthwise through the frontal bone, this was classified as 'zero' (Figure 1a) . When the FP line passed the frontal bone anteriorly, its position was 'negative' (Figure 1b) . When the FP line passed the frontal bone posteriorly, its position was 'positive' (Figure 1c ). The MNM angle was defined as the angle in the midsagittal plane between the lines maxilla-nasion and mandible-nasion (Figure 1d) . NBL was measured from the nasion to the end of the white distal ossification line (A in Figure 1e ). In cases in which there was a gap between the nasal and the frontal bones (disjunction), the NBL was measured from the distal to the proximal end of the ossification line. To measure the PFSR, first the maxilla-mandible line was drawn between the midpoint of the anterior edge of the mandible and the anterior edge of the maxilla. The line was then extended cranially towards the forehead. Subsequently, the skin covering the forehead was measured between the anterior edge of the bony forehead and the anterior edge of the skin, in a line parallel to the maxilla, and traced from the nasion. This measurement was the PT (B in Figure 1e) . A second measurement, d (C in Figure 1e ), was taken measuring from the anterior edge of the skin (where PT ended), to the point of interception with the maxilla-mandible line. The PFSR was determined by dividing d by PT and the PT:NBL ratio was obtained by dividing PT by NBL. All markers were measured in the same plane.
For assessing reproducibility, all markers in all cases were measured twice by two examiners (F.I.V. and E.J.P.), who were blinded to gestational age and to previous measurements, but not to karyotype.
Data were compared with reference values derived from previous reports on euploid fetuses 23 -25,27 in which the NBL and PT have been shown to increase with gestation, from 3.3 mm at 15 weeks to 9.6 mm at 33 weeks (NBL = −6.927 + (0.83 × GA) − (0.01 × GA 2 )) and from 2.3 mm at 15 weeks to 6.1 mm at 33 weeks (PT = (0.212 × GA) − 0.873), respectively, where GA is gestational age in weeks. The MNM angle, PT:NBL ratio and PFSR are stable throughout gestation, with a mean of 13.5
• (95 th centile, 16.9
(95 th centile, 0.80) and 0.97 (5 th centile, 0.55), respectively. Measurements below the 5 th centile (for NBL and PFSR) or above the 95 th centile (for MNM angle, PT and PT:NBL ratio) of the reference ranges, were considered abnormal. An FP line that was not 'zero' was considered abnormal 22, 26 . PT and NBL were expressed as multiples of the median (MoM) in order to correct for gestational age.
Additional ultrasound findings, such as markers and/or structural anomalies 28 , were documented, specifying whether they were observed at the initial routine second-trimester scan or during the subsequent advanced morphological ultrasound examination after referral for karyotyping. 
Statistical analysis
In all cases, intraclass correlation coefficients were calculated to analyze intra-and interobserver variability. Student's t-test was used to analyze differences between measurements; P < 0.05 was considered statistically significant. MoM values were calculated for gestation-dependent markers. Data were analyzed using the statistical software SPSS 21.0 for Windows (SPSS Inc., Chicago, IL, USA) and Excel for Windows 2000.
RESULTS
Data of 45 fetuses with trisomy 18 were available for analysis (six on stored 3D volumes and 39 on stored 2D images). At initial examination, median maternal age was 37 (range, 26-46) years and median gestational age was 21 + 2 (range, 14 + 5 to 31 + 5) weeks. Two cases were excluded, as the profile view was not midsagittal. In two cases, the fetal mandible was not visualized optimally and consequently the FP line, MNM angle and PFSR could not be analyzed. The maxilla was not visualized optimally in one case, and in another the fetus had an orofacial cleft, therefore the MNM angle and PFSR could not be measured. All markers in the same fetus were measured successfully in 39 cases. The intra-and interobserver variability of the measurements recorded are presented in Table 1 .
The mean ± SD values for NBL, MNM angle, PT, PT:NBL ratio and PFSR were 3.76 ± 1.62 mm, 16.67 ± 3.61
• , 4.25 ± 1.33 mm, 1.39 ± 1.00 and 0.87 ± 0.40, respectively. The NB was absent in three *As FP line was not a continuous variable (negative, zero or positive), it was not possible to calculate mean differences. FP, fetal profile; ICC, intraclass correlation coefficient; MNM, maxilla-nasion-mandible; NBL, nasal bone length; PFSR, prefrontal space ratio; PT, prenasal thickness. (7.0%) cases. The FP line was negative in 46.3% of cases, zero in 53.7% and positive in no case. The MNM angle, FP line, PT:NBL ratio and PFSR did not change significantly with gestational age, whereas NBL and PT were significantly correlated with gestational age (P < 0.001). All markers were associated with trisomy 18, and all had a P < 0.001 except for PFSR (P = 0.044). The detection rate (DR), false-positive rate (FPR), positive likelihood ratio and negative likelihood ratio of all markers in screening for trisomy 18 are shown in Table 2 . Of the six markers, the PT:NBL ratio had the best screening performance, with a DR of 88.4%, followed by NBL, with a DR of 83.7%. There was no case in which the six markers were all normal or all abnormal. In all cases, at least one of the six markers was abnormal. Various combinations of the four strongest markers (NBL, FP line, MNM angle and PT:NBL ratio) yielded similar DRs, ranging between 72% and 95% (Table 3) . When NBL-MoM, MNM angle, FP line, PT-MoM, PT:NBL ratio and PFSR were compared, the PT:NBL ratio was significantly correlated to NBL-MoM and PT-MoM (P < 0.01), and the MNM angle was correlated to the FP line and PFSR (P = 0.015 and P < 0.01, respectively).
Gestational age at the time of examination did not influence the DR of the markers, with the exception of PT, for which the DR was significantly higher with advancing gestation (P < 0.01). Figure 2 shows the individual markers plotted against their normal ranges throughout gestation 23 -25,27 and Figure 3 shows the proportion of outcomes of the FP line in comparison with those of euploid fetuses 26 . Table 4 shows the proportion of trisomy-18 fetuses with abnormal features (markers other than profile markers, pathological conditions or structural anomalies) observed at the initial ultrasound scan and at the advanced ultrasound examination at the referral center. It was not possible to retrieve data of the initial scan for all fetuses. In this cohort, a mean of 1.1 'soft' ultrasound markers or other abnormal findings (such as choroid plexus cyst or polyhydramnios) and 0.9 structural anomalies were observed per fetus at the first scan, and 2.3 soft markers and 2.1 structural anomalies per fetus at the advanced referral scan (Table 4 ). All fetuses had at least one soft marker at both the initial scan and the advanced scan. In 22% of fetuses, no structural anomalies were observed at the initial scan compared with 2% at the advanced scan.
DISCUSSION
In this study, we report for the first time on the use of profile markers in trisomy 18 that have previously been investigated extensively in Down syndrome. We have shown that the highest DR (88%) of trisomy 18 is obtained when the PT:NBL ratio is used, closely followed by NBL (DR, 84%).
One of the main findings of this study is that, in second-trimester trisomy-18 fetuses, the NBL is in most cases exceptionally small, even smaller than in those with Down syndrome 21 . Nasal hypoplasia has been reported in association with several chromosomal disorders including Down syndrome, trisomy 18, trisomy 13 and Turner syndrome, among which Down syndrome is the most extensively investigated 21,29 -32 . A short NB has been reported in about 53% of trisomy-18 fetuses in the first trimester and in 67% in the second trimester when combined with an enlarged nuchal fold 13, 14, 31 .
This study indicates that NB hypoplasia in trisomy 18 seems to become more pronounced with advancing gestation. Growth restriction, a very common feature of trisomy 18 33 , may be an explanation for this finding. Another common feature of trisomy 18 is micrognathia, which is also a common finding in triploidy and Turner syndrome, and it has been suggested that it is associated with an abnormal karyotype in 66% of cases when observed prenatally 30, 34, 35 . It is not surprising that markers taking into account micrognathia, such as the MNM angle and the FP line, have a better performance in screening for trisomy 18 than in screening for Down syndrome 21 . This is the first study investigating the MNM angle and the FP line in fetuses with trisomy 18. Two other facial angles, the fronto-maxillary-facial (FMF) angle and the mandibulo-maxillary-facial (MMF) angle, have been described by Borenstein et al. 36 in the first trimester of trisomy-18 fetuses. The FMF angle reflects midfacial hypoplasia and MMF the relationship between mandible and maxilla. The DR of the MMF angle in trisomy 18 (33%) is lower than the 56% reported here for the MNM angle, at a FPR of 5%. However, the MNM angle has a wide range and the highest inter-and intraobserver variability. A negative FP line is caused by micrognathia and/or a sloping forehead, both common in trisomy 18 20 . In this cohort, we found a negative FP line in 46% of cases. This is a modest DR compared with those of the NBL and PT:NBL ratio, however the additional value of this marker in screening for trisomy 18 is the fact that the FP line is never negative in euploid fetuses 26 , implying an FPR of 0%. Moreover, Down syndrome fetuses more frequently show a positive FP line 22 . Hence, in the presence of nasal hypoplasia, a positive FP line is suggestive of Down syndrome and a negative FP line of trisomy 18. Prenasal edema, a common feature of Down syndrome, is far less common in trisomy 18, as reflected in the poor performance of PT and PFSR. However, the addition of PT did slightly improve the DR of NBL when combined in a ratio. The PFSR is a marker that takes into account the position of the mandible and prenasal thickening. Micrognathia increases the PFSR value, however, prenasal thickening reduces it, as is the case in Down syndrome 21 . The DR of PFSR in trisomy 18 was 21% (PFSR value < 5 th centile). We therefore hypothesize that, in trisomy-18 fetuses, the effect of micrognathia on the PFSR may be counterbalanced by the presence of prenasal thickening.
In reporting additional ultrasound findings in this cohort, we make a distinction between findings observed at the initial (usually routine) second-trimester ultrasound scan and findings at the advanced ultrasound examination, carried out by fetal medicine experts after referral. In women who did not undergo first-trimester screening, a systematic evaluation of facial markers at the 20-week scan may alert the sonographer to a possible aneuploidy, especially when obvious structural anomalies are not observed. This is substantially different from when (subtle) anomalies are observed when there is already a suspicion of aneuploidy that has warranted referral to a fetal medicine unit.
At the routine scan, an average of 1.1 soft markers and abnormal findings, mostly choroid plexus cysts and single umbilical artery, and 0.9 structural anomalies, were seen in each fetus. Interestingly, alongside congenital heart disease and major skeletal defects, choroid plexus cysts and overlapping fingers were the most frequently observed minor anomalies at the advanced ultrasound examination (70% and 60%, respectively). Overlapping fingers are highly associated with trisomy 18 37 , in contrast to choroid plexus cysts 38 that, if isolated, are poorly associated with trisomy 18 37, 39 . In almost a quarter of trisomy-18 fetuses, no major anomaly was observed at the initial scan. This strengthens our belief that there may be a role for the systematic and routine evaluation of facial markers at the 20-week scan. In fact, in our experience, even women who have declined Down syndrome screening prefer to be informed about the chance of their fetus being affected by a lethal condition, such as trisomy 18.
A limitation of this study is its retrospective nature and the fact that the examiners were not blinded to karyotype. Ideally, a repeatability and reproducibility study should be performed not only by re-measuring the ultrasound markers on stored images, but also by re-acquiring the desired images. Owing to the retrospective nature of the study the latter was not possible, and the reproducibility figures therefore relate exclusively to the reproducibility of the measurement. Furthermore, it was not possible to retrieve data on additional ultrasound findings at the initial scan in all fetuses.
In conclusion, this study shows that when gross anomalies are absent at the second-trimester ultrasound scan, trisomy 18 can be detected effectively by the combination of markers for micrognathia (MNM angle and FP line) and a small NB (NBL and PT:NBL ratio). We prefer a combination of PT:NBL ratio and FP line; the PT:NBL ratio is in fact the strongest marker for trisomy 18 (and Down syndrome), while the FP line can differentiate between trisomy 18 and Down syndrome. Furthermore, both markers are independent of gestation and therefore a fixed cut-off can be used.
